TFC250117C46500
- 0.10
- +0.05+100.00%
Truist Financial Newsroom
Truist Financial Remains a Hold on ANI Pharmaceuticals (ANIP)
Truist Financial Gives a Buy Rating to IAC/InteractiveCorp. (IAC)
Truist Financial Remains a Buy on Edgewise Therapeutics (EWTX)
Progyny (PGNY) Gets a Hold From Truist Financial
Barclays Maintains Truist Financial(TFC.US) With Hold Rating, Maintains Target Price $51
Barclays Reaffirms Their Hold Rating on Truist Financial (TFC)
Truist Financial Keeps Their Buy Rating on Kimbell Royalty Partners (KRP)
Truist Financial Reaffirms Their Buy Rating on Scholar Rock Holding (SRRK)
Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA)
Truist Financial Remains a Buy on Biogen (BIIB)
Onestream, Inc. Class A (OS) Gets a Buy From Truist Financial
Raymond James Maintains Truist Financial(TFC.US) With Buy Rating, Raises Target Price to $51
Raymond James Adjusts Price Target on Truist Financial to $51 From $47, Maintains Outperform Rating
Truist Financial Reaffirms Their Hold Rating on BWX Technologies (BWXT)
Truist Financial Remains a Buy on Bristol-Myers Squibb (BMY)
Incyte (INCY) Receives a Hold From Truist Financial
Truist Financial Sticks to Its Hold Rating for Amgen (AMGN)
Truist Financial Downgrades Merck & Company (MRK) to a Hold
Truist Financial Gives a Buy Rating to GFL Environmental (GFL)
HSBC Upgrades Truist Financial(TFC.US) to Buy Rating, Raises Target Price to $50